Skip to main content

Market Overview

WeissLaw LLP Reminds CBMG, GMHI, NOVS, and TRNE Shareholders About Its Ongoing Investigations

Share:

NEW YORK, Oct. 30, 2020 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) in connection with the proposed interested-party acquisition of the company by an entity consisting of CBMG's CEO Tony Liu, members of the company's management, and a consortium of investors.  Under the terms of the agreement, CBMG shareholders will receive $19.75 in cash for each share of CBMG common stock that they own.  If you own CBMG shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/cellular-biomedicine-group-inc/    

Gores Metropoulos Inc. (NASDAQ:GMHI)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Gores Metropoulos Inc. (NASDAQ:GMHI) in connection with the proposed merger of the company with privately-held Luminar Technologies, Inc ("Luminar").  Under the terms of the merger agreement, GMHI will acquire Luminar through a reverse merger, with Luminar surviving as a publicly-traded company.  If you own GMHI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/gores-metropoulos-inc/   

Novus Capital Corporation (NASDAQ:NOVS)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Novus Capital Corporation (NASDAQ:NOVS) in connection with the company's proposed merger with AppHarvest, Inc ("AppHarvest").  Under the terms of the merger agreement, NOVS will acquire AppHarvest through a reverse merger, with AppHarvet surviving as a publicly-traded company.  If you own NOVS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/novs/   

Trine Acquisition Corp. (NYSE:TRNE)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Trine Acquisition Corp. (NYSE:TRNE) in connection with the company's proposed merger with privately-held tech manufacturing company, Desktop Metal, Inc. ("Desktop Metal").  Under the terms of the merger agreement, TRNE will acquire Desktop Metal through a reverse merger that will result in Desktop Metal becoming a publicly-traded company.  At closing, current TRNE shareholders will own only 33% of the combined company, leaving the majority stake to Desktop Metal's existing shareholders.  If you own TRNE shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/trine-acquisition-corp/

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-reminds-cbmg-gmhi-novs-and-trne-shareholders-about-its-ongoing-investigations-301164247.html

SOURCE WeissLaw LLP

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com